|
US2016376661A1
|
|
A method for predicting responsiveness to a treatment with an egfr inhibitor
|
|
EP3000895A1
|
|
A method for predicting responsiveness to a treatment with an EGFR inhibitor
|
|
WO2014044853A1
|
|
A new method for classification of liver samples and diagnosis of focal nodule dysplasia, hepatocellular adenoma, and hepatocellular carcinoma
|
|
WO2014044854A1
|
|
A method for prognosis of global survival and survival without relapse in hepatocellular carcinoma
|
|
WO2013132074A2
|
|
A genotyping test for assessing risk of autism
|
|
US2014370029A1
|
|
Method for predicting responsiveness to a treatment with an EGFR inhibitor
|
|
WO2011138372A1
|
|
A new combination of eight risk alleles associated with autism
|
|
WO2011076783A2
|
|
A method for evaluating a risk for a transmissible neuropsychiatric disorder
|
|
WO2011067296A1
|
|
A combination of eight risk alleles associated with autism
|
|
AU2010361988A1
|
|
Compositions and methods for diagnosing autism
|
|
CA2726078A1
|
|
A combination of risk alleles associated with autism
|
|
CA2726080A1
|
|
A method for autism prediction
|
|
US2011027393A1
|
|
Human diabetes susceptibility eefsec gene
|
|
EP2134866A2
|
|
Human diabetes susceptibility tnfrsf10b gene
|
|
WO2008122673A2
|
|
Human diabetes susceptibility tnfrsf10a gene
|
|
WO2008122672A1
|
|
Human diabetes susceptibility tnfrsf10d gene
|
|
WO2008122671A1
|
|
Human diabetes susceptibility tnfrsf10c gene
|
|
CA2677413A1
|
|
Human diabetes susceptibility pebp4 gene
|
|
CA2677848A1
|
|
Human diabetes susceptibility shank2 gene
|
|
EP2102368A1
|
|
Human diabetes susceptibility btbd9 gene
|
